Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL

Clinical trial NCT06321289 · RECRUITING

Trial details

NCT number: NCT06321289
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma,B Cell

Start date: 2024-03-20
Primary completion: 2026-03-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.